Read About Us
Stay up to date on Differential Bio news, product updates, events and more.
.png){kind=icon}
March 26, 2025
Munich-Based AI Biotech Startup Differential Bio Emerges from Stealth with €2M Pre-Seed to Transform Biomanufacturing with Cutting-Edge Virtual Scale-up Platform
Munich, Germany – March 26, 2025 – Differential Bio, a Munich-based AI biotech startup, emerged from stealth today with €2 million in pre-seed funding to redefine biomanufacturing. Its Virtual Scale-up Platform seamlessly integrates advanced microbiology, lab automation, and artificial intelligence, unlocking unprecedented speed and efficiency to optimize and scale bioprocesses. By eliminating critical bottlenecks, Differential Bio is not just improving biomanufacturing—it’s transforming it into a smarter, faster, and more scalable industry.
Christian Spier
Simulate smarter. Scale faster.
•Last updated: February 4, 2025
Featured
October 1, 2026
Differential Bio and FermBase by CREMER publish joint whitepaper on the development of Y-Base Blend
Munich, October 1, 2026 - From more than 50,000 possible trace-element combinations to one commercial blend within six months: Differential Bio and FermBase by CREMER share how automated experiments and machine learning led to Y-Base Blend, which outperformed partners' in-house recipes in half of the cases.
Christian Spier
October 15, 2026
Differential Bio and FermBase by CREMER enter into strategic partnership for AI-driven solutions in the fermentation industry
Munich, October 15, 2026 - From the first experiment to industrial production: Differential Bio and FermBase by CREMER join forces in a strategic partnership, combining robotic laboratory automation and machine learning with CREMER's raw material and supply-chain expertise for the fermentation industry.
Christian Spier
February 25, 2026
A Probiota Global Origin Story: Differential Bio joining CanBiocin on stage
CanBiocin and Differential Bio took the Probiota Global 2026 stage in Dublin to present a joint case study on robotics- and AI-guided media optimization for a commercial L. reuteri production strain. We shared how high-throughput experimentation and AI-driven inference translated into clear, production-relevant improvements, validated beyond small-scale screening and anchored in real process constraints and economics.
Christian Spier
February 19, 2026
Differential Bio Featured in BCG Report Linked to Germany’s Hightech Agenda as an Exemplar for Cross‑Cutting Technologies in Biotech
Differential is highlighted in the report Wachstumspfade für Deutschland - Roadmap zur wettbewerbsfähigen Hightech‑Nation (Feb 2026), a publicly available roadmap report published by Boston Consulting Group (BCG) and UnternehmerTUM that is aligned with Germany’s Hightech Agenda. The mention positions Differential as an exemplar of “biotechnological cross‑cutting technologies” (biotech x AI) and provides validation that maps directly onto the German government’s stated priority areas and execution logic (scaling, transfer, and industrial impact).
Christian Spier
August 28, 2025
Differential Bio and CanBiocin Publish Case Study on AI‑Driven Media Optimization for Probiotic Pet Food Ingredients
August 28, 2025 - Today, we’re excited to share a new case study detailing our collaboration with CanBiocin Inc., a Canadian leader in species‑specific probiotics for companion animals. This case study highlights how our integrated, robotics‑enabled, AI‑guided workflow improved performance and economics for an already commercialized Limosilactobacillus reuteri production strain.
Christian Spier
Want to stay informed?
.png){kind=logo}
We work with you on making microbial growth predictable, scalable, and cost-effective through robotic lab automation and AI-driven insights.
